IGHAX
Price
$12.43
Change
-$0.03 (-0.24%)
Updated
Jun 30 closing price
Net Assets
347.49M
PRAFX
Price
$19.15
Change
-$0.08 (-0.42%)
Updated
Jun 30 closing price
Net Assets
10.26B
Interact to see
Advertisement

IGHAX vs PRAFX

IGHAX vs PRAFX Comparison Chart in %
View a ticker or compare two or three
VS
IGHAX vs. PRAFX commentary
Jul 01, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IGHAX is a Hold and PRAFX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PRAFX has more cash in the bank: 10.3B vs. IGHAX (347M). PRAFX pays higher dividends than IGHAX: PRAFX (2.58) vs IGHAX (1.40). IGHAX was incepted earlier than PRAFX: IGHAX (18 years) vs PRAFX (16 years). IGHAX (1.20) is less costly to investors than PRAFX (0.93). IGHAX is a more actively managed with annual turnover of: 67.00 vs. PRAFX (48.30). IGHAX has a lower initial minimum investment than PRAFX: IGHAX (0) vs PRAFX (2500). PRAFX annual gain was more profitable for investors over the last year : 29.02 vs. IGHAX (2.70). PRAFX return over 5 years is better than : 44.66 vs. IGHAX (17.96).
IGHAXPRAFXIGHAX / PRAFX
Total Expense Ratio1.100.93118%
Annual Report Gross Expense Ratio1.200.93129%
Fund Existence18 years16 years-
Gain YTD3.9118.76745%
Front LoadN/AN/A-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets347M10.3B3%
Annual Yield % from dividends1.402.5854%
Returns for 1 year2.7029.029%
Returns for 3 years24.2949.0550%
Returns for 5 years17.9644.6640%
Returns for 10 years78.15109.4571%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MPITX19.180.05
+0.26%
BNY Mellon International M
MIDHX33.84N/A
N/A
MFS International New Discovery R3
GCLSX28.20N/A
N/A
Goldman Sachs Large Cp Val Insghts Svc
EIVAX15.41N/A
N/A
Allspring Special Large Cap Value A
RYDKX112.75N/A
N/A
Rydex Dow Jones Industrial Average® C